Efficacy and safety of the direct switch to indacaterol/glycopyrronium from salmeterol/fluticasone in non ‐frequently exacerbating COPD patients: The FLASH randomized controlled trial

Respirology, EarlyView.

Source: Respirology - August 3, 2018 Category: Respiratory Medicine Authors: Peter A. Frith , Samiha Ashmawi , Srikanth Krishnamurthy , Alev Gurgun , Sashka Hristoskova , Virginia Pilipovic , Anna Marie Hamann , Arthur Backer , Petter Olsson , Konstantinos Kostikas , Dina V. Diaz , Source Type: research